Approximately 16% of Worldwide Cancers Caused By Preventable Infections (05-17-2012)

Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading

Women More Likely to Survive Melanoma Than Men (05-16-2012)

Women are 30 percent more likely to survive melanoma than men, according to the results of a study published in the Journal of Clinical Oncology.[1] Melanoma is a deadly type of skin cancer that arises from melanocytes, which are cells located in the... Continue Reading

Overall Health, Not Just Age, is an Important Factor in Treatment of Non-Small Cell Lung Cancer (05-14-2012)

Younger patients with non-small cell lung cancer (NSCLC) are more likely to receive treatment than older patients, regardless of overall health and prognosis, according to the results of a study published in the Journal of Clinical Oncology. Lung cancer... Continue Reading

Vitamin E Supplementation Appears to Increase Risk of Prostate Cancer (05-11-2012)

The final analysis of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) indicated that vitamin E increased the risk of developing prostate cancer in otherwise healthy men by 17% when compared to placebo. The results of the study were published... Continue Reading

FDA Approves New Silicone Gel-Filled Breast Implant (05-9-2012)

The U.S. Food and Drug Administration (FDA) has approved a silicone gel-filled breast implant manufactured by Sientra Inc for breast augmentation in women at least 22 years old and breast reconstruction in women of any age. As a condition of approval,... Continue Reading

Higher Risk Women Benefit from Earlier Breast Screening (05-3-2012)

Women with dense breasts or a first-degree relative with breast cancer are twice as likely as average-risk women to develop breast cancer in their 40s[1] and these women would benefit from beginning mammography screening at age 40[2], according to the... Continue Reading

Fatigue After Breast Cancer Treatment May Fade Over Time (05-1-2012)

Cancer-related fatigue (CRF) is common after treatment for early stage breast cancer, but new results indicate that the phenomenon fades over time, according to a study published in the Journal of Clinical Oncology. Breast cancer is the most commonly... Continue Reading

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (04-30-2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Intensity-Modulated Radiation Therapy May Prove Better than Other Radiation Techniques for Prostate Cancer (04-26-2012)

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, intensity-modulated radiation therapy (IMRT) was associated with fewer gastrointestinal side effects and fewer hip fractures, but more erectile dysfunction... Continue Reading

Addition of Avastin Does Not Improve Survival in Older Patients with NSCLC (04-25-2012)

The addition of Avastin (bevacizumab) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) did not improve survival rates in patients over age 65 with advanced NSCLC, according to the results of a study published in the Journal... Continue Reading